VFEND - Important Safety Information from Pfizer as approved by the Irish Medicines Board

Notice type: 3rd Party Publications

Date: 08/11/2010

 

Problem Or Issue:
Important Safety Information communication from Pfizer on the potential risk of squamous cell carcinoma (SCC) associated with long term VFEND therapy

Important Safety Information - VFEND


« Back